Community/Retail

Particularly during summer months, counsel patients about sunscreen recommendations and drug-induced photosensitivity prevention strategies.

A Danish study confirms no link between aluminum in childhood vaccines and chronic diseases, reinforcing vaccine safety amid rising skepticism.

Adam James, PharmD, and Chris Altman, PharmD, explain how pharmacists can build trust and reduce vaccine hesitancy by clearly communicating thimerosal’s limited role in today’s immunizations and addressing patient concerns with empathy and education.

Even patients who are confident in their abilities often use incorrect technique

Carrie Harney, JD, of US Pharmacopeia (USP) discusses how proposed tariffs could impact generic drug supply chains, sterile injectable shortages, and pharmacy operations, underscoring the need for policy incentives and manufacturing diversification.

Results from the ZENITH trial show sotatercept's promise for pulmonary arterial hypertension treatment.

The plan first addresses monoclonal antibodies but could eventually be applied to all compounds seeking FDA approval.

In the double-blind portion of Vibrance-1, alixorexton improved wakefulness while eliciting broad benefits in patient-reported outcomes.

From AI-powered prescription fulfillment to the expansion of PillPack for Medicare patients, Carey outlines how Amazon Pharmacy is streamlining access, improving affordability, and setting the stage for a more patient-centered health care future.

Pharmacy deserts can have far-reaching consequences, especially in rural and low-income communities.

Challenges faced by individuals living with HIV include weight gain, cardiovascular risks, and healthy aging strategies.

A pharmacist's termination raises critical questions about staffing policies, patient safety, and ethical obligations in healthcare. Explore the ongoing legal battle.

Different dietary strategies, including intermittent energy restriction, enhance weight loss and blood sugar control in those with type 2 diabetes (T2D) and obesity.

GLP-1 anti-obesity medications enhance testosterone levels, aiding weight management and improving health outcomes for those with obesity and type 2 diabetes (T2D).

These tools provide real-time data, enabling earlier intervention and prevention of serious health complications.

Lessons from the past season could strengthen prevention and drive vaccinations for 2025-2026.

Influenza vaccination significantly reduces cases and enhances community immunity, highlighting pharmacists' vital role in promoting public health.

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

Education initiatives, facilitation, and immunization on the part of pharmacists were found to significantly increase uptake of pneumococcal vaccines among older adults.

Long-term obesity accelerates aging in young adults, increasing risks for cardiovascular diseases and metabolic dysfunction.

Researchers unveil a groundbreaking method using polypurine hairpins to inhibit PCSK9, offering a promising alternative for lowering cholesterol and reducing cardiovascular risk.

Immunocompromised patients, especially transplant recipients, face heightened RSV risks, leading to severe infections and complications.

The FDA recently approved gepotidacin oral tablets for the treatment of uncomplicated urinary tract infections (UTIs).

Unused, unwanted, and expired medications pose a serious threat to both public health and the environment.

Unique barriers can lead to psychiatric medication adherence rates as low as 26%.

Pharmacists play a vital role in translating global health news into actionable knowledge for their communities.